Exane BNP Paribas downgraded RH (RH) to Underperform from Neutral with a price target of $253, down from $274. The company’s leverage and liquidity shorten the timeframe for it to deliver results, the ...

Exane BNP Paribas downgraded RH (RH) to Underperform from Neutral with a $253 price target The firm sees a negative risk/reward skew with significant downside to consensus estimates. Published first ...

Stocks on Wednesday settled mixed. The overall market found support from the as-expected US October consumer price report.

Emerson Electric (EMR) is up more than +1% after BNP Paribas Exane initiated coverage on the stock with a recommendation of ...

Exane BNP Paribas has recently raised BILL Holdings Inc (BILL) stock to Outperform rating, as announced on September 12, 2024, according to Finviz. Earlier, on August 26, 2024, BMO Capital Markets had ...

On Tuesday, BorgWarner Inc. (BWA) stock saw a modest uptick, ending the day at $35.14 which represents a slight increase of $0.48 or 1.38% from the prior close of $34.66. The stock opened at $34.55 ...

As previously reported, Exane BNP Paribas downgraded Accenture (ACN) to Neutral from Outperform with a $375 price target The firm sees a slower growth recovery Accenture after IBM and Capgemini ...

Fintel reports that on October 8, 2024, Exane BNP Paribas initiated coverage of Samsara (NYSE:IOT) with a Neutral recommendation. As of September 25, 2024, the average one-year price target for ...

One commentator called the award of the IRIS² contract to the SpaceRISE consortium comprising Eutelsat, SES and Hispasat and ...

See what positions big money is taking on your favorite stocks. Click here for access. * An analyst from Exane BNP Paribas ...

(Alliance News) - Applied Nutrition PLC on Tuesday announced its set price range being targeted for its planned initial public offering this month. (Sharecast News) - JD Sports Fashion's share ...

On Wednesday, BNP Paribas (OTC:BNPQY) Exane updated its stance on Qorvo Inc (NASDAQ:QRVO) shares, downgrading the stock from Outperform to Neutral, while setting a price target of $80.00. The firm's ...